Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 4, 2025 • 2:30 AM ET

Date/Time Source News Release
08/30/2023 08:30 AM EDT ACCESSWIRE Bloomios Reports Q2 2023 Financial Results
06/09/2023 08:31 AM EDT PR Newswire Bloomios Appoints Kevin Henry as National Sales Director
06/01/2023 03:50 PM EDT PR Newswire Bloomios Reports Q1 2023 Revenue up 30% Sequentially and 84% Y/Y to $2.75 Million
03/27/2023 08:31 AM EDT PR Newswire Bloomios Appoints Industry Veteran, Joe Reid, as Chief Manufacturing Officer
10/27/2022 08:31 AM EDT PR Newswire Bloomios Completes $23.5 Million Acquisition of Leading Gummy Manufacturer
10/27/2022 08:30 AM EDT PR Newswire Upexi Announces Sale of Select CBD Assets for $23.5 Million
10/20/2022 03:00 PM EDT Newsfile Bloomios To Present at The 2022 LD Micro Main Event October 25-27
08/04/2022 04:44 PM EDT PR Newswire Bloomios to Develop and Produce New Range of Private-Label Products Utilizing, Ashwagandha, Melatonin, Kratom, Lion's Mane, Valerian Root, Reishi Mushroom and other Natural Ingredients
05/25/2022 08:31 AM EDT PR Newswire Bloomios to Present at the 2022 LD Micro Invitational June 7-9
05/18/2022 08:31 AM EDT PR Newswire Bloomios Expands Production Capacity by 300%, Setting Stage for Strong Growth in 2022
Page
  • 1
  • 2

Additional News

As of June 4, 2025 • 2:30 AM ET

Date/Time Source News Release
06/01/2023 04:22 PM EDT SeekingAlpha Bloomios reports Q1 results
10/31/2022 01:43 PM EDT Green Market Report Bloomios Buys CBD Gummy Manufacturer for $23.5 Million
05/18/2022 09:14 AM EDT SeekingAlpha Bloomios sets stage for stronger growth, expands production capacity by 300%
04/19/2022 09:39 AM EDT SeekingAlpha Bloomios, Inc. GAAP EPS of -$0.16, revenue of $8.5M
Page
  • 1

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.